|
🐬
|
Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.
P. Kinnunen,
O. Vuolteenaho,
H. Ruskoaho
|
8 |
1993 |
8
🐬
|
|
🐜
|
Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure.
14 auth.
G. Földes,
F. Horkay,
I. Szokodi,
O. Vuolteenaho,
M. Ilves,
K. Lindstedt,
M. Mäyränpää,
Balázs Sármán,
L. Seres,
R. Skoumal,
...
Zoltán Lakó-Futó,
R. Dechatel,
H. Ruskoaho,
M. Tóth
|
8 |
2003 |
8
🐜
|
|
🐢
|
Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer.
O. Vakkuri,
J. Leppäluoto,
O. Vuolteenaho
|
8 |
1984 |
8
🐢
|
|
🐬
|
Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production.
M. Heikkilä,
H. Peltoketo,
J. Leppäluoto,
M. Ilves,
O. Vuolteenaho,
S. Vainio
|
7 |
2002 |
7
🐬
|
|
🐢
|
Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
7 auth.
M. Ala-Kopsala,
J. Magga,
K. Peuhkurinen,
J. Leipälä,
H. Ruskoaho,
J. Leppäluoto,
...
O. Vuolteenaho
|
7 |
2004 |
7
🐢
|
|
🐜
|
Natriuretic Peptides and Mortality After Stroke
9 auth.
A. Mäkikallio,
T. Mäkikallio,
J. Korpelainen,
O. Vuolteenaho,
J. Tapanainen,
K. Ylitalo,
...
K. Sotaniemi,
H. Huikuri,
V. Myllylä
|
7 |
2005 |
7
🐜
|
|
🐬
|
Ultrasonographic and Biochemical Markers of Human Fetal Cardiac Dysfunction in Placental Insufficiency
K. Mäkikallio,
O. Vuolteenaho,
P. Jouppila,
J. Räsänen
|
7 |
2001 |
7
🐬
|
|
🐜
|
GATA-4 Is a Nuclear Mediator of Mechanical Stretch-activated Hypertrophic Program*
10 auth.
S. Pikkarainen,
H. Tokola,
T. Majalahti-Palviainen,
Risto Kerkelä,
N. Hautala,
Suparna S. Bhalla,
...
F. Charron,
M. Nemer,
O. Vuolteenaho,
H. Ruskoaho
|
6 |
2003 |
6
🐜
|
|
🐬
|
Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era.
J. Tapanainen,
K. Lindgren,
T. Mäkikallio,
O. Vuolteenaho,
J. Leppäluoto,
H. Huikuri
|
6 |
2004 |
6
🐬
|
|
🐜
|
Natriuretic peptides during the development of doxorubicin‐induced left ventricular diastolic dysfunction
8 auth.
T. Nousiainen,
E. Vanninen,
E. Jantunen,
J. Puustinen,
J. Remes,
A. Rantala,
...
O. Vuolteenaho,
J. Hartikainen
|
6 |
2002 |
6
🐜
|
|
🐬
|
Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non‐Hodgkin's lymphoma
T. Nousiainen,
E. Jantunen,
E. Vanninen,
J. Remes,
O. Vuolteenaho,
J. Hartikainen
|
6 |
1999 |
6
🐬
|
